2)- . Correction to Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trial.Cancer science. 2023, 114 (12): 4776-4777
3)- Hiroshi Tsuge, Daisuke Kawakita, Yukari Taniyama, Isao Oze, Yuriko N Koyanagi, Megumi Hori, Kayo Nakata, Hiromi Sugiyama, Isao Miyashiro, Izumi Oki, Yoshikazu Nishino, Kota Katanoda, Yuri Ito, Akiko Shibata, Tomohiro Matsuda, Shinichi Iwasaki, Keitaro Matsuo, Hidemi Ito. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.Cancer science. 2023, :
5)- Yefei Zhang, Jiahui Chen, Jia Tian, Yehui Zhou, Yan Liu. Role and function of plakophilin 3 in cancer progression and skin disease.Cancer science. 2023, :
21)- Luyao Sun, Miaola Ke, Mengyuan Yin, Ying Zeng, Yutong Ji, Yiming Hu, Songbin Fu, Chunyu Zhang. Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.Cancer science. 2023, :
24)- Steven Olsen, Yoshiaki Nakamura. Serial comprehensive genomic profiling by next-generation sequencing for patients with metastatic colorectal cancer.Cancer science. 2023, :
26)- Tomohiro Tanaka, Hiroyuki Suzuki, Tomokazu Ohishi, Mika K Kaneko, Yukinari Kato. Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H Mab-77-mG -f.Cancer science. 2023, :
33)- Weina Li, Guohui Han, Feng Li, Peng Bu, Yating Hao, Li Huang, Xiangdong Bai. Cancer cell-derived exosomal miR-20a-5p inhibits CD8 T-cell function and confers anti-programmed cell death 1 therapy resistance in triple-negative breast cancer.Cancer science. 2023, :
35)- Takao Mochizuki, Masachika Ikegami, Toru Akiyama. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.Cancer science. 2023, :
36)- Ning Ding, Guodong Cao, Zhuo Wang, Shengjun Xu, Wenwen Chen. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.Cancer science. 2023, :
41)- . Correction to: Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway.Cancer science. 2023, :
42)- . Correction to LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.Cancer science. 2023, :
45)- Jennifer Tai, Chao-Wei Hsu, Wei-Ting Chen, Sien-Sing Yang, Cheng-Hsun Chiu, Rong-Nan Chien, Ming-Ling Chang. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.Cancer science. 2023, :
48)- . Retraction: Cui S-Z, Lei Z-Y, Guan T-P, et al. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy. Cancer Science. 2020; 111: 1567-1581. https://doi.org/10.1111/cas.14375.Cancer science. 2023, :
49)- Rui Zheng, Si Wang, Jia Wang, Mengnan Zhou, Qi Shi, Beixing Liu. Neuromedin U regulates the anti-tumor activity of CD8 T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1-dependent manner.Cancer science. 2023, :